Adam Palermo is an accomplished scientific leader with years of experience in the field of genomics, genetics, computational biology, and gene therapy. He holds a Ph.D. in Molecular Pharmacology from Stanford University and a B.A. in Biochemical Sciences from Harvard University. Palermo has an impressive career trajectory, including his current role as the VP of Molecular Platform and former senior director and head of Genomics and Computational Biology at Decibel Therapeutics. He's also held various positions at Genzyme, a Sanofi company, ranging from Associate Scientific Director to Senior Scientist.

Throughout his professional journey, Palermo has shown his prowess in leading genomics and computational biology teams. He has a unique ability to unite various aspects of scientific research to achieve a common goal. Palermo's scientific leadership skills have put him at the forefront of gene therapy, and he's been vocal about the opportunities presented by this field. His experience and expertise make him a valuable addition to any scientific team.